BRIEF published on 03/23/2026 at 22:05, 3 days 5 hours ago Inventiva announces its 2025 annual financial results Financial Results Conference Call Investors Steatohepatitis Oral Therapy
BRIEF published on 03/23/2026 at 22:05, 3 days 5 hours ago Inventiva Announces Schedule for 2025 Financial Results Financial Results Conference Call Biopharmaceutical Inventiva MASH
PRESS RELEASE published on 03/23/2026 at 22:00, 3 days 6 hours ago Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results Inventiva to release 2025 full-year financial results on March 30, 2026, followed by a conference call on March 31, 2026. Details on the company's website Financial Results Conference Call Biopharmaceutical Inventiva Therapy
BRIEF published on 03/23/2026 at 09:51, 3 days 18 hours ago JP Morgan Chase & Co. crosses ownership thresholds in INVENTIVA Actions Participation Threshold Crossing JP Morgan Inventiva
BRIEF published on 03/23/2026 at 09:50, 3 days 18 hours ago Threshold crossings at INVENTIVA Shareholders Voting Rights Inventiva Threshold Crossings Shareholders' Agreement
BRIEF published on 03/16/2026 at 09:40, 10 days 18 hours ago JP Morgan Chase reduces its stake in Inventiva Actions Participation Crossing Thresholds JP Morgan Inventiva
BRIEF published on 03/12/2026 at 15:56, 14 days 12 hours ago Threshold Crossing at Inventiva Actions Stock Market Crossing Thresholds JP Morgan Chase & Co. Inventiva
BRIEF published on 02/17/2026 at 14:32, 1 month 9 days ago Threshold Crossing by Deep Track Biotechnology Voting Rights Actions Threshold Crossing Inventiva Deep Track
BRIEF published on 02/17/2026 at 08:35, 1 month 9 days ago Inventiva Reports Preliminary Financial Results for 2025 Financial Results Cash Flow Biopharmaceuticals Inventiva MASH
BRIEF published on 02/17/2026 at 08:35, 1 month 9 days ago Inventiva announces its preliminary financial results for 2025 Financial Results Treasury Biopharmaceutical Public Offering Inventiva
Published on 03/26/2026 at 23:00, 5 hours ago FutureGen Industries Announces Closing of Debt Settlement
Published on 03/26/2026 at 22:05, 5 hours 55 minutes ago BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Published on 03/26/2026 at 22:00, 6 hours ago Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Published on 03/26/2026 at 22:00, 6 hours ago Green Bridge Metals Reports Visible Copper Sulfide Mineralization in Initial 2026 Titac Drilling, Duluth Complex Minnesota
Published on 03/26/2026 at 21:00, 7 hours ago Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Published on 03/26/2026 at 20:48, 7 hours 12 minutes ago Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 8 hours 40 minutes ago Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 19:09, 8 hours 51 minutes ago 2CRSi SA: First Half 2025/26 Results: Revenue of €204.7 million (x9.8) EBITDA of €9.6 million (x4.6)
Published on 03/26/2026 at 18:17, 9 hours 43 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 17:45, 10 hours 15 minutes ago Cegedim: profitability continues to improve
Published on 03/26/2026 at 07:30, 20 hours 30 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
